Rescape has a mission to: -Deliver immersive solutions that deliver significant patient, health economics and equality benefits. -Give every patient in hospital care access to their own VR headset. -Give every patient outside hospital the opportunity to utilise VR care. -Make VR empathy and experience training normal business practice. Rescape’s first product - the now medical device DR.VR® is being used within the NHS, Care Homes and Hospices. DR.VR® is a virtual reality distraction therapy solution that primarily supports pain relief, anxiety/stress and improves patient’s experience. The modular DR.VR® platform is flexible, supporting multiple care and therapeutic pathways including being used within ICU reducing pain, anxiety and assisting in the recovery of patients. The iteration DR.VR® Junior is designed for Paediatric departments and is being used with leading UK Children’s hospitals. The DR.VR® platform is designed to be simple and straightforward to implement even with no prior VR experience. During the pandemic Rescape developed DR.VR® Frontline with a targeted outcome of reducing anxiety of NHS frontline staff. Following a successful feasibility study commercial sales of DR.VR® are now underway. DR.VR® has also been shown delivering a cost effective training solution into the care and blue light services. Rescape is currently focusing on driving adoption within care pathways that can benefit from the impact that DR.VR® can make today and collaborations that build on the DR.VR® platform and technology for future patient benefits tomorrow.
